Angiotensin-receptor blockade, cancer, and concerns.
作者信息
Goldstein Mark R, Mascitelli Luca, Pezzetta Francesca
出版信息
Lancet Oncol. 2010 Sep;11(9):817-8; author reply 821-2. doi: 10.1016/S1470-2045(10)70160-1.
Abstract
摘要
相似文献
1
Angiotensin-receptor blockade, cancer, and concerns.
Lancet Oncol. 2010 Sep;11(9):817-8; author reply 821-2. doi: 10.1016/S1470-2045(10)70160-1.
2
Angiotensin-receptor blockade, cancer, and concerns.
Lancet Oncol. 2010 Sep;11(9):820-1; author reply 821-2. doi: 10.1016/S1470-2045(10)70159-5.
3
Angiotensin-receptor blockade, cancer, and concerns.
Lancet Oncol. 2010 Sep;11(9):818-9; author reply 821-2. doi: 10.1016/S1470-2045(10)70162-5.
4
Angiotensin-receptor blockade, cancer, and concerns.
Lancet Oncol. 2010 Sep;11(9):819; author reply 821-2. doi: 10.1016/S1470-2045(10)70163-7.
5
Angiotensin-receptor blockade, cancer, and concerns.
Lancet Oncol. 2010 Sep;11(9):819-20; author reply 821-2. doi: 10.1016/S1470-2045(10)70178-9.
6
[Angiotensin II type 1 receptor blockade and risk of cancer].
Ugeskr Laeger. 2010 Nov 1;172(44):3054; discussion 3054.
7
Angiotensin-receptor blockers and cancer: urgent regulatory review needed.
Lancet Oncol. 2010 Jul;11(7):605-6. doi: 10.1016/S1470-2045(10)70142-X. Epub 2010 Jun 11.
8
Opinions in hypertension. ARBs and risk of cancer: international and South African expert comment.
Cardiovasc J Afr. 2010 Nov-Dec;21(6):338-41.
9
Use of angiotensin receptor blockers and the risk of cancer.
Circulation. 2011 Apr 26;123(16):1729-36. doi: 10.1161/CIRCULATIONAHA.110.007336. Epub 2011 Apr 11.
10
Ask the doctor. I read that angiotensin-receptor blockers cause cancer. I take one (Diovan) for my blood pressure. Should I stop?
Harv Heart Lett. 2010 Dec;21(4):8.
引用本文的文献
1
Clinical applicability of renin-angiotensin system inhibitors in cancer treatment.
Am J Cancer Res. 2021 Feb 1;11(2):318-336. eCollection 2021.
2
Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts.
BMC Med. 2014 Feb 13;12:28. doi: 10.1186/1741-7015-12-28.
3
Angiotensin II type 1 receptor antagonists in the treatment of hypertension in elderly patients: focus on patient outcomes.
Patient Relat Outcome Meas. 2011 Jul;2:27-39. doi: 10.2147/PROM.S8384. Epub 2011 Jan 25.
4
A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors.
Vasc Health Risk Manag. 2011;7:297-313. doi: 10.2147/VHRM.S15541. Epub 2011 May 19.
Zotero 插件